Perflenapent
A perfluorocarbon compound investigated as an ultrasound contrast agent and oxygen carrier, with potential applications in enhancing diagnostic imaging. Its high gas-dissolving capacity allows it to carry oxygen to tissues in experimental settings.
Peso molecular
288,0300 g/mol
LogP
4,50
TPSA
0,00 Ų
Regla de cinco de Lipinski
Cumple
Mecanismo de acción
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
Estructura 2D
Cite this structure
Embed this structure
SMILES
FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F
InChI
InChI=1S/C5F12/c6-1(7,2(8,9)4(12,13)14)3(10,11)5(15,16)17
Molecular Formula
C5F12
HBD / HBA
- / 12
Enlaces Rotables
2
Átomos Pesados
17
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Preguntas frecuentes
A perfluorocarbon compound investigated as an ultrasound contrast agent and oxygen carrier, with potential applications in enhancing diagnostic imaging. Its high gas-dissolving capacity allows it to carry oxygen to tissues in experimental settings.
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
Yes, Perflenapent is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1899801. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 12675. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="perflenapent"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/perflenapent/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/perflenapent/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/perflenapent/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="perflenapent"></drugfyi-drug>